Skip to main content

American Healthcare REIT, Inc.

For the period ended Apr 9, 2026. Filed Apr 9, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 9, 2026 · Filed Apr 9, 2026

AHR$57.91+3.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrantþ

Filed by a Party other than the Registrant¨

Check the appropriate box:

¨Preliminary Proxy Statement
¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
þDefinitive Proxy Statement
¨Definitive Additional Materials
¨Soliciting Material Pursuant to §240.14a-12

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

þNo fee required.
¨Fee paid previously with preliminary materials:
¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

18191 Von Karman AvenueSuite 300Irvine, CA 92612(949) 270-9200

April 9, 2026

Dear Stockholder:

On behalf of our Board of Directors, I cordially invite you to attend the 2026 Annual Meeting of Stockholders of American Healthcare REIT, Inc., to be held on June 24, 2026 at 8:00 a.m. local time, at the Irvine Marriott, located at 18000 Von Karman Avenue, Irvine, California 92612. We look forward to your attendance.

The accompanying Notice of Annual Meeting of Stockholders and Proxy Statement describe the formal business to be acted upon by our stockholders, including the election of the nine directors named in this Proxy Statement; the ratification of the appointment of our independent registered public accounting firm; and the approval, on an advisory (non-binding) basis, of the compensation paid to our named executive officers.

Moreover, we will provide an update on our portfolio and company performance at the 2026 Annual Meeting of Stockholders.

Every stockholder’s vote is important and assists us in establishing the necessary quorum to conduct business at the 2026 Annual Meeting of Stockholders. Regardless of the number of shares of our common stock you own, it is very important that your shares be represented at the 2026 Annual Meeting of Stockholders. Accordingly, whether or not you intend to be present at the 2026 Annual Meeting of Stockholders, we appreciate your prompt attention in voting and submitting your proxy. You may do this by completing, signing and dating the accompanying proxy card and returning it in the accompanying self-addressed, postage-paid return envelope. You also may authorize a proxy via the Internet at https://www.proxyvote.com or by telephone by dialing toll-free 1 (800) 690-6903. Please follow the directions provided in the proxy statement. This will not prevent you from attending and voting in person at the 2026 Annual Meeting of Stockholders, but will assure that your vote will be counted if you are unable to attend the 2026 Annual Meeting of Stockholders.

Thank you for your attention to this matter and for your continued support of, and interest in, our company.

Sincerely,

Jeffrey T. Hanson

Chairman of the Board of Directors andInterim Chief Executive Officer and President

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.